Science Corporation, the startup from former Neuralink president and co-founder Max Hodak, has enlisted a top neurobiologist to lead the first U.S. human trials for its biohybrid brain-computer interface.
Dr. Murat Günel, chair of Yale Medical School’s Department of Neurosurgery, has signed on as a scientific adviser after two years of discussions. His goal is to surgically place the first sensor for a future interface — one that will eventually combine lab-grown neurons with electronics — into a patient’s brain.
